Moreover, the heterogeneous expression of B7H3 in gliomas and other tumors were also observed (Zhang et al., 2019), and B7H3 seems to favor its expression in middle line gliomas (Zhou et al., 2013). This evidence concerns the gene CD276 and glioma.